PT65358B - Process for preparing a pharmaceutical composition for treatment of central nervous system disorders - Google Patents

Process for preparing a pharmaceutical composition for treatment of central nervous system disorders

Info

Publication number
PT65358B
PT65358B PT65358A PT6535876A PT65358B PT 65358 B PT65358 B PT 65358B PT 65358 A PT65358 A PT 65358A PT 6535876 A PT6535876 A PT 6535876A PT 65358 B PT65358 B PT 65358B
Authority
PT
Portugal
Prior art keywords
preparing
treatment
pharmaceutical composition
nervous system
central nervous
Prior art date
Application number
PT65358A
Other languages
English (en)
Portuguese (pt)
Other versions
PT65358A (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT65358A publication Critical patent/PT65358A/pt
Publication of PT65358B publication Critical patent/PT65358B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT65358A 1975-07-16 1976-07-12 Process for preparing a pharmaceutical composition for treatment of central nervous system disorders PT65358B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (2)

Publication Number Publication Date
PT65358A PT65358A (en) 1976-08-01
PT65358B true PT65358B (en) 1978-01-09

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65358A PT65358B (en) 1975-07-16 1976-07-12 Process for preparing a pharmaceutical composition for treatment of central nervous system disorders

Country Status (11)

Country Link
US (1) US4016273A (member.php)
BE (1) BE844203A (member.php)
CA (1) CA1062159A (member.php)
DE (1) DE2630394A1 (member.php)
DK (1) DK319776A (member.php)
FI (1) FI762053A7 (member.php)
FR (1) FR2317912A1 (member.php)
GB (1) GB1525425A (member.php)
NL (1) NL7607918A (member.php)
PT (1) PT65358B (member.php)
SE (1) SE7608114L (member.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
IL152360A0 (en) * 2000-04-19 2003-05-29 Genentech Inc Sustained release formulations
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
IL159048A0 (en) * 2001-06-21 2004-05-12 Genentech Inc Sustained release formulation
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
BRPI0418304A (pt) * 2004-01-07 2007-05-02 Trimeris Inc peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
JP4940152B2 (ja) * 2005-01-05 2012-05-30 イーライ リリー アンド カンパニー パモ酸オランザピン二水和物
CN101415723B (zh) * 2006-02-02 2014-06-25 特里梅里斯公司 具有改良生物学特性的hiv融合抑制肽
ES2346005T3 (es) * 2006-07-27 2010-10-07 Cognis Ip Management Gmbh Procedimiento para la obtencion de glicerina.
WO2008124013A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
JP2010540528A (ja) * 2007-09-25 2010-12-24 トリメリス，インコーポレーテッド 治療的抗ウイルス性ペプチドの新規合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
US4016273A (en) 1977-04-05
NL7607918A (nl) 1977-01-18
CA1062159A (en) 1979-09-11
PT65358A (en) 1976-08-01
GB1525425A (en) 1978-09-20
BE844203A (fr) 1977-01-17
SE7608114L (sv) 1977-01-17
FI762053A7 (member.php) 1977-01-17
DK319776A (da) 1977-01-17
FR2317912A1 (fr) 1977-02-11
DE2630394A1 (de) 1977-02-03
FR2317912B1 (member.php) 1979-04-13

Similar Documents

Publication Publication Date Title
PH12825A (en) A method of preparing solid pharmaceutical dosage forms
PT65358A (en) Process for preparing a pharmaceutical composition for treatment of central nervous system disorders
IL49790A0 (en) A process for the preparation of a disposable adsorption column useful for radioimmunoassays
CS193539B2 (en) Process for preparing derivatives of salicylanilide
GB1545628A (en) N-substituted 2-methoxybenzenesulphonamides process for preparing them and medicaments containing them
JPS525750A (en) Process for preparing polyamine
EG12969A (en) Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines
PT64878A (en) Process for the preparation of new indolylalkylpiperidines
CS190549B2 (en) Process for preparing derivatives of 2-/4-aryl-4-hydroxypiperidinomethyl/tetralone and-indanone
EG12413A (en) Process for preparing of 11-desoxy-16-aryloxy-pentanorprostaglandins
PT65522A (en) Process for the preparation of polyamine compounds
CS189782B2 (en) Process for preparing derivatives of diaminoandrostane
JPS5277041A (en) Process for preparing polyamine
BE840354A (fr) Procede de preparation d'agents therapeutiques
CS186234B2 (en) Process for preparing new derivatives of ferocene
GB1552658A (en) Process for the preparation of s substituted phosphorodichloridothiolates
PT64933A (en) Process for the preparation of therapeutically valuable 2-oxo-1-pyrrolidinylacetamide
CS191981B2 (en) Process for preparing derivatives of 5-androsten-17-one
GR59904B (en) Process for the preparation of amine derivatives
HU175227B (hu) Sposob poluchenija novykh proizvodnykh aroil-fenil-naftalina s kontraceptivnojj aktivnost'ju
ZA7628B (en) Pharmaceutical preparation for the treatment of circulatory disorders
PH13439A (en) Method of preparing solid pharmaceutical unit dosage form
EG12277A (en) Process for preparing of 1-acyl-1,2,3,4 tetrahydro-6-quinolinols compounds
JPS51125335A (en) Process for preparing orthooderivatives of paraaisopropenylphenol
GR60053B (en) Preparation process of new substituted arylalkylamines